Analystreport

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Vetr Inc. from a "strong-buy" rating to a "buy" rating. They now have a $21.73 price target on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com